The Role of Immunogenetics in the Host-Parasite Interaction of Chagas Disease: Implications for Personalized Medicine. [PDF]
Hassnain M +5 more
europepmc +1 more source
Parasitological cure and clinical benefits of benznidazole treatment in patients from the Jequitinhonha Valley, MG, Brazil, with recent chronic infection by Trypanosoma cruzi II. [PDF]
de Lana M +9 more
europepmc +1 more source
Harnessing Phytonanotechnology to Tackle Neglected Parasitic Diseases: Focus on Chagas Disease and Malaria. [PDF]
García M, Magi MS, García MC.
europepmc +1 more source
Benznidazole-Associated Rash in the Setting of Incorrectly Diagnosed Chronic Chagas Disease. [PDF]
Beatty NL, Patel PP, Alcala RF.
europepmc +1 more source
Design, Synthesis, and Trypanosomicidal Evaluation of Eugenol-Based Azole Hybrids: Discovery of an <i>In Vitro</i> Active and Selective Compound. [PDF]
Machado JVC +10 more
europepmc +1 more source
Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains. [PDF]
Raimundo BVB +9 more
europepmc +1 more source
Advancing <i>Trypanosoma cruzi</i> N-myristoyltransferase as a drug target for Chagas disease through <i>in silico</i> discovery and biochemical evaluation. [PDF]
González García D +9 more
europepmc +1 more source
Spectroscopic (FT-IR and FT-Raman) and quantum chemical study on monomer and dimer of benznidazole from DFT and molecular docking approaches. [PDF]
Paneru TR +5 more
europepmc +1 more source
Statins do not reduce the parasite burden during experimental <i>Trypanosoma cruzi</i> infection. [PDF]
Razzaq S +7 more
europepmc +1 more source
Long-term outcomes of benznidazole treatment in chronic Chagas disease: A 27-year cohort study of parasitological cure and death in the Jequitinhonha Valley, Brazil. [PDF]
Assis JCSO +10 more
europepmc +1 more source

